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Objective: Primary chest wall neoplasm represents only 5% of chest wall neoplasm and among them primary
chest wall lymphoma is uncommon.
Methods: A 28-year-old man had no history of tuberculous pyothorax or artificial pneumothorax therapy but did
have a 4-month history of dyspnea, fever, chills, and night sweats. On physical examination, a mass about 103
10 cm was noted on the anterior chest wall on the right side, and computed tomographic scan demonstrated that it
originated from the pleural wall. A 42-year-old man was admitted with intermittent left hemithoracic pain from
about 6 months before his visit. A 53 5-cm tender mass in the posterior wall of the left hemithorax was palpated.
Computed tomography showed mild plural effusion and erosion in the posterior segment of the left ninth rib. Sur-
gery was performed for histologic diagnosis.
Results:With the diagnosis of large B cell lymphoma, chemotherapy was prescribed for the first patient, and the
patient has been in complete remission for more than 5 months. For the second patient, the left ninth rib along with
the originated mass was completely resected and chemotherapy was prescribed. The patient has been in complete
remission for more than 8 months.
Conclusion: Treatment of primary chest wall lymphoma was not clear and various treatment strategies were con-
sidered. Remission of considerable duration in our patients leads us to suggest that surgery followed by adjuvant
chemotherapy can provide a reasonable outcome in patients in whom the chest wall lymphoma is the only site of
disease.The chest wall is the origin for a wide variety of malignant
neoplasms, which include primary neoplasm, adjacent neo-
plasm with local invasion, and metastatic lesions. Primary
chest wall neoplasm in comparison with the other two
groups of chest wall neoplasm mentioned herein is rare,
representing only 5%.1,2 Among primary chest wall neo-
plasms, chest wall lymphoma is uncommon. To date, only
a few cases of primary malignant lymphoma arising from
the pleura or the rib with no history of tuberculous pyo-
thorax and artificial pneumothorax therapy have been re-
ported, most of which occurred in Japan.3,4 Treatment of
primary chest wall lymphoma was not clear and various
treatment strategies were considered. Surgery followed by
adjuvant chemotherapy can provide a satisfactory outcome
in patients in whom the chest wall lymphoma is the only
site of disease.5
Herein we report the clinical and pathologic characteris-
tics as well as treatment strategy of non-Hodgkin lymphoma
in 2 patients with a solitary chest wall mass.
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PATIENT 1. A 28-year-old nonsmoking man had a 4-month
history of dyspnea, fever, chills, and night sweats. He had
been known to have end-stage renal disease for 7 years
and rejected kidney transplantation. He had no history of tu-
berculous pyothorax, artificial pneumothorax therapy, or
other remarkable medical disease. On physical examination,
a mass of about 10 3 10 cm was palpated on the anterior
wall of chest on the right side.
Significant laboratory findings were as follows: hemoglo-
bin 6.3 g/dL, erythrocyte sedimentation rate 60 mm/h, and
serum C-reactive protein 3þ. Chest radiograph revealed a ho-
mogeneous chest wall mass and computed tomography (CT)
demonstrated a tumor in the pleural wall (Figure 1). Exci-
sional biopsy was performed for histologic diagnosis.
Histologic study showed diffuse infiltration of large lym-
phocytes with vesicular and prominent nucleoli and rela-
tively abundant cytoplasm. Mitotic activity was high and
an area of necrosis was seen. Immunohistochemical staining
of the specimen was positive for leukocyte common antigen,
CD20, and Ki67 and negative for CD3, vimentin, desmin,
chromogranin, neuron specific enolase, CD99, and actin.
Under the diagnosis of large B cell lymphoma, chemo-
therapy was prescribed for the patient. The patient has
been in complete remission for more than 5 months.
PATIENT 2. A 42-year-old Iranian man was admitted with
a chief symptom of intermittent left hemithoracic pain,
which had begun about 6 months before his visit and had be-
come chronic in the past 2 months. Pain radiated to behindurgery c December 2008
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the ribs in the anterior and transverse process of spine in the
back. He had a history of spinal cord epandimoma 13 years
earlier. He had smoking history of 20 packs per year. Phys-
ical examination showed a 53 5-cm tender mass in the pos-
terior wall of left hemithorax, which extended between the
sixth and tenth thoracic vertebrae. He did not have lymph-
adenopathy or hepatosplenomegaly.
Laboratory examination of the blood revealed a hemoglo-
bin value of 12.2 g/dL and a white blood cell of about 9900.
CT demonstrated mild plural effusion and also erosion in the
posterior segment of left ninth rib (Figure 2). Bone scan con-
firmed a lesion in the posterior arch of left ninth rib. Surgery
was performed for histologic diagnosis. With the patient un-
der general anesthesia, a mass originating from the ninth rib
was resected. Histologic study showed diffuse infiltration of
a large lymphocyte with vesicular and prominent nucleoli
and relatively abundant cytoplasm. Mitotic activity was
high and an area of necrosis was present. Immunohisto-
chemical staining of the specimen was positive for leukocyte
common antigen, CD20, Ki67, and CD20 and negative for
CD3 and vimentin. The tumor was diagnosed as large B
cell lymphoma (Figure 3).
FIGURE 1. CT scan without contrast: Soft tissue mass lesion in posterior
aspect of right chest wall with extension into right hemithorax accompanied
by pleural thickening and effusion.The Journal of Thoracic and CA biopsy specimen of the bone marrow showed no evi-
dence of lymphoma. The left ninth rib along with the origi-
natal mass was completely resected and chemotherapy was
prescribed for the patient. The patient has been in complete
remission for more than 8 months after the operation
(Figures 1 to 4).
DISCUSSION
Primary malignant lymphoma originating from the pleura
is uncommon, comprising only 2.4% of primary chest wall
tumors.6 Most pleural lymphomas develop in patients with
chronic tuberculous pyothorax or a history of artificial pneu-
mothorax. Most cases of this disease are reported in Japan,3,7
FIGURE 2. CT scan demonstrated an expansile bony lytic destructive le-
sion in the posterior arch of the left rib with invasion into the left pleural
space and accompanied by a posterior soft tissue component.
FIGURE 3. Histologic study shows diffuse infiltration of large lympho-
cytes with vesicular and prominent nucleoli and relatively abundant cyto-
plasm, which is compatible with large B cell lymphoma.ardiovascular Surgery c Volume 136, Number 6 1473
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tients are referred to medical centers for chest pain, dyspnea,
and constitutional symptoms such as fever or recent weight
loss. Pyothorax-associated lymphoma occurs in 2% of pa-
tients between 22 and 55 years after the onset of tuberculo-
sis. The mean age of patients is 51.8 years with a male
predominance of 5:2.3,9 The absolute mechanism of pyo-
thorax-associated lymphoma is not detected yet. Chronic
stimulation of B cells results in production of growth factors
such as interleukin 6 and interleukin 10, which play impor-
tant roles in neoplastic cell growth.3,7,8 Other mechanisms
that are considered for primary pleural lymphoma are ante-
cedent autoimmune disease and Epstein-Barr virus infec-
tion.3 Our first patient has received immunosuppressive
therapy for kidney transplantation, which can be a mecha-
nism for his disease.
Despite the prevalence of tuberculous in Iran, no pyo-
thorax-associated lymphoma is documented yet, because ar-
tificial pneumothorax therapy is not performed as a routine
treatment. Our first patient had a primary pleural lymphoma
without a history of tuberculous pyothorax or artificial pneu-
mothorax as a treatment for lung tuberculosis. Primary pleu-
ral lymphoma without chronic pyothorax is a very
uncommon tumor. According to previous studies, our pa-
tient is the tenth case reported since 1996.3
The diagnosis and treatment of pleural lymphoma is con-
troversial. Previous study indicated that fine needle aspira-
tion or nonexcisional biopsy as a diagnostic modality is
not appropriate because of wrong diagnosis owing to inade-
FIGURE 4. Follow-up study 7 months later shows no evidence of tumor
residue or recurrence.1474 The Journal of Thoracic and Cardiovascular Squate tissue specimen and the risk of tumor implanta-
tion.2,5,10 According to some suggestions, all primary
chest wall tumors should be subjected to at least excisional
biopsy, although highly suspected malignancies should re-
ceive wide radical resection or subsequent resection for
safe margins.1,2,5 Nonexcision biopsy should be done only
in patients with suspicion of metastasis or hematologic dis-
ease, who do not benefit from aggressive surgical resec-
tion.1,2,5,11 In patient 1, excisional biopsy was done for
diagnosis and then chemotherapy was used. The patient
was in complete remission after about 5 months’ follow-
up. Because of the rarity of cases, the treatment has not
been definitely determined. Although the primary treatment
for lymphoma is chemotherapy, surgery followed by adju-
vant chemotherapy can provide a satisfactory outcome in pa-
tients in whom the chest wall lymphoma was the only site of
disease.5
Our second patient had a primary non-Hodgkin lym-
phoma in the ribs. Primary lymphoma of the bone (PLB),
which was first reported by Oberling,12 now is recognized
as an independent clinicophathologic entity.4,13 PLB ac-
counts for approximately 4.7% of extranodal lymphomas.14
The majority of cases occur in long bones, pelvis, or spine,
and rib involvement is rare (2% to 15% of cases of
PLB).4,13 The mean age at presentation for PLB, according
to a review by Ostrowski and associates,15 was 46 years with
male predominance. The most frequent symptoms are pain,
swelling, and B symptoms (fever, night sweats, and body
weight loss), as in other lymphoma conditions.4,16 Because
imaging study of chest wall tumor suggesting PLB is not di-
agnostic, a histologic specimen is needed.2,5,17 The treat-
ment in general is conservative, based on the stage of
disease. There is no definite therapeutic scheme. Local radi-
ation is recommended, and additional systemic chemother-
apy seems to be effective.16
As discussed earlier, we chose surgery for histologic diag-
nosis. The left eighth rib and the original mass were com-
pletely resected in our patient. The diagnosis was
performed by histology and confirmed by immunopheno-
typing. After radical resection, we prescribed chemotherapy
for the patient. The patient has been in complete remission
for more than 8 months since the operation.
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